Cargando…
miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8
Drug resistance remains a large obstacle for the treatment of ovarian cancer. miRNAs have been reported to be involved in cisplatin (CDDP) resistance in ovarian cancer. The aim of the present study was to investigate the function and mechanism of miR-199a-3p in the CDDP resistance in ovarian cancer....
Autores principales: | Cui, Yajie, Wu, Fengqin, Tian, Defu, Wang, Ting, Lu, Tianjie, Huang, Xiying, Zhang, Peilian, Qin, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868401/ https://www.ncbi.nlm.nih.gov/pubmed/29436681 http://dx.doi.org/10.3892/or.2018.6259 |
Ejemplares similares
-
miR-146a Inhibits Proliferation and Enhances Chemosensitivity in Epithelial Ovarian Cancer via Reduction of SOD2
por: Cui, YaJie, et al.
Publicado: (2016) -
miR-199a modulates cisplatin resistance in ovarian cancer by targeting Hif1α
por: Feng, Xue, et al.
Publicado: (2017) -
Long noncoding RNA HULC contributes to paclitaxel resistance in ovarian cancer via miR-137/ITGB8 axis
por: Huang, Bo, et al.
Publicado: (2021) -
miR-222 regulates brain injury and inflammation following intracerebral hemorrhage by targeting ITGB8
por: Bai, Yan-Yan, et al.
Publicado: (2020) -
ITGB3 promotes cisplatin resistance in osteosarcoma tumors
por: Li, Qian, et al.
Publicado: (2023)